Rheumatoid arthritis patients on Medicare seeing increased costs for specialty medications
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual ...
May 1, 2020
0
4